HealthTech

Buprenorphine Access Still Lags, Even After Major Feder...

While the drop in drug overdose deaths is promising, and could potentially be pa...

Weekly Roundup – March 8, 2025

Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...

FDA and NIH nominees sail through Senate hearings; Tari...

Welcome back to Endpoints Weekly! This week was another busy one in DC, with two...

This Hospital Exec Wants Nurses to Join the Ambient Lis...

Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes ...

This Hospital Exec Wants Nurses Should Join the Ambient...

Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes ...

Start of 2025 comes with generic drug price decreases, ...

More generic drug prices decreased than increased in January, a new report from ...

FDA approves Neurotech therapy for rare eye disease 

The FDA on Thursday approved Neurotech Pharmaceuticals’ cell therapy for an eye ...

Bayer eyes capital raise as it grapples with Monsanto c...

Bayer is asking shareholders to authorize a potential equity offer that would al...

How bluebird's buyout offer went from $100M upfront to ...

Bluebird bio went from a high-flying $10 billion company in 2018 during the heyd...

What FDA, NIH hearings say about Trump drug, health policy

President Donald Trump's nominees for NIH director and FDA commissioner sailed t...

Johnson & Johnson Discontinues Pivotal Depression Drug ...

J&J said aticaprant showed insufficient efficacy in a Phase 3 test in major depr...

How Can EHRs Support the Shift to Value-Based Care and ...

[Sponsored] MedCity News Editor in Chief Arundhati Parmar moderated a webinar wi...

Key Insights & Top Takeaways from HIMSS25 Day 4

This week, Healthcare IT Today is attending HIMSS25 in Las Vegas! For those not ...

At $300M Kardigan startup, former MyoKardia team unveil...

When some former MyoKardia execs reunited with $300 million for a new "heart hea...

Jeb Keiper steps down from Nimbus CEO post, business ch...

Nimbus Therapeutics is getting a new CEO after more than six years, as Jeb Keipe...

GEM HEALTH Secures $7M to Advance Virtual Sleep Care

GEM HEALTH’s Series A round was co-led by HealthTrend Capital and LFE Capital an...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.